Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Inventory Average (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Inventory Average data on record, last reported at $482500.0 in Q3 2025.

  • For Q3 2025, Inventory Average fell 77.05% year-over-year to $482500.0; the TTM value through Sep 2025 reached $482500.0, down 77.05%, while the annual FY2024 figure was $1.3 million, 32.85% down from the prior year.
  • Inventory Average reached $482500.0 in Q3 2025 per BTAI's latest filing, down from $574000.0 in the prior quarter.
  • Across five years, Inventory Average topped out at $2.6 million in Q2 2024 and bottomed at $482500.0 in Q3 2025.
  • Average Inventory Average over 4 years is $1.6 million, with a median of $1.8 million recorded in 2022.
  • Peak YoY movement for Inventory Average: surged 86.66% in 2023, then crashed 77.57% in 2025.
  • A 4-year view of Inventory Average shows it stood at $1.7 million in 2022, then grew by 18.16% to $2.0 million in 2023, then tumbled by 45.02% to $1.1 million in 2024, then tumbled by 56.22% to $482500.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $482500.0 in Q3 2025, $574000.0 in Q2 2025, and $660500.0 in Q1 2025.